1-1 of 1
Arnd Schwebig
Close
Save search
Sort by
Journal Articles

A Comparison of Proposed Biosimilar and Originator Filgrastim for the Prevention of Neutropenia in Patients with Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Phase III, Randomized, Double-Blind Trial (The PIONEER study)

Free
Kimberly Blackwell, Vladimir Semiglazov, Pedro Gascon, Roumen Nakov, Stefan Kramer, Arnd Schwebig, MD, Nadia Harbeck
Journal: Blood
Blood (2014) 124 (21): 5133.
https://doi.org/10.1182/blood.V124.21.5133.5133
Published: 2014